ALT, alanine aminotransferase; BMI, body mass index; T2DM, type 2 diabetes mellitus; BCLC, Barcelona Clinic Liver Cancer; MAFLD, metabolic dysfunction-associated fatty liver disease, HCC, hepatocellular carcinoma. This evidence concerns the gene GPT and type 2 diabetes mellitus.